Animal genetics company Genus said it used gene editing to develop pigs that are resistant to porcine reproductive and respiratory syndrome, a costly viral disease affecting hogs. Colombia has approved sale of the pigs, and Genus, based in Britain, said it anticipates a decision from the FDA in the first half of 2024, “followed by… » Read More
The Ag Insider content is only available to members.